| « Previous month | Next month » |
Novis is currently seeking experts to develop as science journalists across several of its pharmaceutical and food industry news services.
Scientists have developed a nanoparticle that can penetrate a tumour, cut off its blood supply and release a lethal dose of anti-cancer toxins, while leaving healthy cells unscathed.
According to a recent survey, the pharma industry spent an estimated $1.25 billion for each new molecular entity (NME) approved by the FDA in 2004. The figure represents the second consecutive year in which this figure has declined from the high of $1.82 billion in 2002, and reflects the sharp upturn in NME approvals in 2003 and 2004.
Germany's Evotec is to provide a broad range of pharmaceutical discovery and chemical development services to Procter & Gamble Pharmaceuticals in a lift for its outsourcing business.
Labcyte has announced that it has closed its latest round of financing in which $21 milllion was raised. The funds will be used to expand its low-volume liquid handling business with a view to marketing the next Labcyte product in the genomics and proteomics market.
A portable nano detection tool could be used by processors to ensure food safety, say the project's team of European researchers.
An improved new statistical method developed by genome researchers, is set to streamline the computation required to identify the potential locations in the genome, as well as linking more gene expression traits to two loci.
NanoDrop Technologies has introduced a fluorospectrometer to its line of analytical instruments that allow researchers to measure ever-smaller sample amounts making it ideal for today's drug research environment.
Buck Systems, part of Niro Pharma Systems, has launched a laboratory-scale blender that allows users to analyse powders as they are being blended and monitor changing powder characteristics, achieving the ideal blend as quickly and economically as possible, according to the firm.
Chemicals and pharmaceuticals firm Merck KGaA saw turnover rise but pretax earnings dip in the second quarter of 2005, although the results were skewed by the gain from its divestment of its laboratory distribution business VWR International.
Lab and process equipment company Sartorius closed the first half of 2005 with increases in sales revenue and earnings, with a good performance by its filter business driven by demand from the biopharmaceutical industry.
Nabi Biopharmaceuticals has opened its new vaccine manufacturing facility in which commercial quantities of StaphVAX [Staphylococcus aureus Polysaccharide Conjugate Vaccine] will be produced. StaphVAX is currently in phase III development to prevent S. aureus infections in end-stage renal (kidney) disease (ESRD) patients.
A new method of pooling food samples speeds up the detection of a range pathogenic and spoilage bacterium, according to UK-based Matrix MicroScience.
Sigma-Aldrich has launched a handful of laboratory equipment and technological developments that could prove useful in drug discovery. The life science company is currently in the midst of a reorganisation of its operating structure involving Sigma's two life science and high-tech research businesses.
Invitrogen has opened a bioproduction facility in Australia to make bovine sera products and reagents used in basic research and the production of vaccines and biotherapeutic drugs.
The new company has been launched to provide laboratory-based drug discovery and clinical trials services to the pharmaceutical and biotech industries. Lab21 services include lead identification and optimisation, resistance profiling, clinical candidate selection and selectivity evaluation in pre-clinical situations.
US-based laboratory equipment specialist VWR International has boosted its presence in Europe via the acquisition of Technical Service Lab, a Dutch calibration and validation company.
A new in silico technique for generating enhanced predictions for ADME/Tox research could have new implications in developing novel drug techniques in combating drug-resistant infectious diseases and cancer.
Life Therapeutics has announced the acquisition of Pyramid Biological Corporation in a deal that increases Life Therapeutics presence in the source plasma sector - a market that has nearly doubled, from $125 million (€103 million) to $230 million, averaging over 6 per cent annual growth.
Sigma-Aldrich is reorganising its operating structure, although its fine chemicals unit SAFC will be unaffected by the restructuring.
Metabolic profiling company SIDMAP has opened a new laboratory in West Los Angeles, California, US.
The Cosmetic, Toiletry and Fragrance Association is asking for comment from industry members on soon-to-be published guidelines for specific microbiology applications aimed at making personal care products safer, reports Simon Pitman.
Thermo Electron announces the launch of its chromatography data system (CDS), which provides enhancements in data integration with laboratory information management systems (LIMS) for improved laboratory productivity.
Meat from the lab directly to the table is still in an experimental stage right now, but a team of scientists have jumped ahead of the crowd by indicating how it might be done on an industrial scale.
A disposable flask bioreactor designed by Swiss company Integra Biosciences has been shown to boost cell densities in mammalian cell culture by a factor of 10 in a study.
A new laboratory designed to improve the quality of barley and oats could have major implications for makers of breakfast cereals, beverages and bakery goods.
Applied Biosystems and joint venture partner MDS Sciex have formed an alliance with Dionex to develop combined ion chromatography and mass spectroscopy approaches for the accurate and sensitive measurement of a wide range of target analytes.
The lack of food science recruits in the UK is unsustainable if the country wants to remain a centre for innovation and avoid becoming the food industry's global admin office, says the head of Britain's most prestigious food science course to Chris Mercer.
Radleys of the UK has introduced a new refrigerated heat circulator that can improve the efficiency of process development, according to the company.
Hamilton launches two new products, which are set to aid the facilitation of automation in laboratories, placing tedious and time-consuming processes in the hands of cutting edge and cost-effective technology for automation.
Greater emphasis on the responsibilities of top management are among the changes ushered in by a revised international standard for testing and calibration laboratories.
The National Food Laboratory has developed a new test method for the detection of Sudan Red food dye, a potential carcinogen that has been the focus of numerous product recalls.
A new gene scanning technology, developed by researchers in the UK, is set to have a major impact on healthcare in the future with the potential to lead a very personalised genetic profile relevant to drug prescribing, leading to more personalised medicine and screening.
Millipore has bolstered its position in the contract testing business with the acquisition of a Dutch contract laboratory.
A new DNA-based test machine for identifying deadly bacteria is faster, easier to use and more precise than some methods currently used by food and beverage processors, according to research by the US's department of agriculture.
US researchers have identified a specific pathway that causes inflammation in lung tissue, a discovery that could help in the design of more targeted drug treatments for patients with various lung diseases, including cystic fibrosis, reports Wai Lang Chu.
Sigma Aldrich has launched a new kit, which incorporates a novel approach for the fluorescent quantification of proteins offering numerous advantages over existing kits that include reversible covalent binding, large dynamic range, improved sensitivity, and emission stability.
| « Previous month | Next month » |